cabergoline
– preparations
– side effects
|
 |
| 1-7 of 7 Results |
|
|
|
 |  | Cabergoline
Goodman & Gilman's Pharmacology > Chapter 55. Pituitary Hormones and Their Hypothalamic Releasing Hormones > Prolactin > Agents Used to Treat Syndromes of Prolactin Excess | | |  | Cabergoline
Harrison's Online > Chapter 333. Disorders of the Anterior Pituitary and Hypothalamus > Prolactin > Prolactinoma > Prolactinoma: Treatment | | |  | Cabergoline
Greenspan's Basic & Clinical Endocrinology > Chapter 5. Hypothalamus & Pituitary Gland > Pituitary & Hypothalamic Disorders > Pituitary Adenomas > Prolactinomas > Treatment > Dopamine Agonists | | | | Table 352-4 Unsafe Drugs in Porphyria
Harrison's Online > Chapter 352. The Porphyrias > The Hepatic Porphyrias > Acute Intermittent Porphyria > Clinical Features | | | | Table 366-4 Levodopa Formulations and Dopamine Agonists Used in Parkinson's Disease
Harrison's Online > Chapter 366. Parkinson’s Disease and Other Extrapyramidal Movement Disorders > Parkinson's Disease > Parkinson's Disease: Treatment > Initiation of Therapy | | | | Side Effects
Harrison's Online > Chapter 333. Disorders of the Anterior Pituitary and Hypothalamus > Prolactin > Prolactinoma > Prolactinoma: Treatment | | |  | Cabergoline (generic, Dostinex)
Basic and Clinical Pharmacology > Chapter 37. Hypothalamic & Pituitary Hormones > Preparations Available > Prolactin Antagonists (Dopamine Agonists) | |
|
| 1-7 of 7 Results |
|
|
|
|